Abbreviations: CIAP ϭ chronic idiopathic axonal polyneuropathy; CMAP ϭ compound muscle action potential; DML ϭ distal motor latency; HMSN ϭ hereditary motor and sensory neuropathy; MCV ϭ motor conduction velocity; SCV ϭ sensory conduction velocity; SNAP ϭ sensory nerve action potential; VPT ϭ vibration perception treshold
Introduction
In 10% of patients with chronic axonal polyneuropathy no is, in most cases, a dominantly inherited, sensorimotor polyneuropathy also with slow progression. Nerve biopsies etiology can be found even after extensive evaluation (McLeod et al., 1984) and long term follow-up (Notermans confirm the axonal nature of this neuropathy (Behse and Buchthal, 1977; Harding and Thomas, 1980a) . Although the et al., 1993 Although the et al., , 1994 . We have denominated this entity chronic idiopathic axonal polyneuropathy (CIAP) (Notermans et al., peak age of onset is in the second decade, a substantial number of patients may develop symptoms after the age of 1993, 1994) . Patients usually present in middle or old age with mild sensory and/or motor symptoms, and show only 40 years (Buchthal and Behse, 1977; Harding and Thomas, 1980a) . In contrast with the demyelinative form of HMSN, slow progression. Severe disability does not occur (Notermans et al., 1994) .
type 1, where reduced nerve conduction velocities provide a reliable diagnosis in at-risk individuals without apparent Hereditary motor and sensory neuropathy (HMSN) type 2 symptoms (Harding and Thomas, 1980c) , affected HMSN and Thomas, 1980a) and in cases of doubt chromosomal evaluation was performed for 1p17 or 1q lesions. type 2 family members without overt clinical features cannot easily be traced with electromyography (Timmerman et al., The 47 HMSN type 2 patients originated from 25 families. Autosomal dominant inheritance was most likely in 42 1996) . The number of patients identified within HMSN type 2 families is therefore small and, although linkage studies patients of 22 families. X-linked inheritance could not be excluded in 10 of these families with no clear male-to-male have revealed a relation with chromosomes 1p36 (Ben Othmane et al., 1993) and 3q (Kwon et al., 1995) , the gene inheritance. However, in these 10 families males were never more severely affected than females, which makes X-linked has still to be found. As a consequence, in patients with CIAP, a diagnosis of HMSN type 2 should also be considered, HMSN less likely (Bergoffen et al., 1993) . In three patients from two families, an autosomal dominant inheritance mode even when detailed kinship history and neurological evaluation of family members do not reveal an inheritable was suspected as one of the parents had had a history of walking difficulties, which could not be confirmed as both disease (Dyck et al., 1981) .
We set up a study to investigate whether extensive clinical parents were deceased. In two patients from one family, autosomal recessive inheritance could not be excluded as and electrophysiological testing of patients with CIAP or HMSN type 2 with onset after the first decade could reveal both parents showed no abnormalities on neurological and electrophysiological investigation. Clinically, these patients significant differences between the two groups. If these differences exist, a hereditary cause in sporadic patients with differed from the patients with autosomal recessive inheritance described by Harding and Thomas (1980b) and CIAP becomes unlikely. To assess whether the results are possibly influenced by differences in age of onset between by Gabreëls-Festen et al. (1991) since onset had not been in the first or early second decade and they were not as the groups, we compared CIAP patients with HMSN type 2 patients with age of onset Ͼ40 years. In addition, within the severely affected. HMSN type 2 group, we compared patients whose age of onset was Ͻ40 years with those whose age of onset was Ͼ40 years. Furthermore, the clinical course of HMSN type
Patient evaluation
For this study, all patients were examined by the same 2 was studied by analysing the relationship between the duration of the disease and its severity. neurologist (L.L.T.). History taking and clinical examination were carried out in a standard fashion, including an extensive interview to determine age and nature of complaints at onset, nature and distribution of motor and sensory symptoms, the
Patients and methods
concurrence of other diseases or intoxications (medication, alcohol abuse, occupational and environmental toxic agents)
Patients
During 1995 and 1996, 48 patients with CIAP [31 male, 17 and a detailed kinship history. Age of onset was defined as the moment when patients consulted a physician for the first female; age 67 Ϯ 7 years (mean Ϯ SD)] and 47 patients with HMSN type 2 (25 male, 22 female; age 53 Ϯ 14 years) time with symptoms which were probably related to the polyneuropathy. were admitted to the study. Patients originated from the University Hospital Utrecht (40 CIAP, 29 HMSN type 2),
The neurological examination was performed according to a standardized protocol (Notermans et al., 1993) . Seven the University Hospital Nijmegen (18 HMSN type 2) and the St Lucas-Andreas Hospital Amsterdam (eight CIAP). On muscles or muscle groups in both arms (deltoid, biceps brachii, triceps brachii, wrist extensors, finger extensors, entry, electrophysiological assessment confirmed the axonal nature of the neuropathy in all patients. In 20 CIAP patients finger flexors and interosseus) and seven muscles or muscle groups in both legs (iliopsoas, quadriceps, hamstrings, and 20 HMSN type 2 patients electrophysiological testing was repeated at the University Hospital Utrecht according to anterior tibial, gastrocnemius, peroneus and toe extensors) were measured using the MRC scale (Medical Research procedures described below. All patients gave informed consent, and the study was approved by the Committee for Council, 1976) . Summation of the scores could lead to a maximum motor score of 140. The following sensory Human Research, University Hospital, Utrecht.
Patients were diagnosed as having CIAP if no cause modalities were examined: touch, pin prick, vibration sense and joint position sense. The sensory system was graded as was found after extensive clinical and laboratory evaluation (Notermans et al., 1993) . A detailed kinship history was follows: touch and pin prick sense normal ϭ 4; distal to wrist/ankle abnormal ϭ 3; distal half forearm/leg abnormal ϭ taken and if suspicion of the existence of a polyneuropathy arose, suspected family members were analysed, both 2; distal to elbow/knee abnormal ϭ 1; distal to axilla/ groin abnormal ϭ 0. Vibration sense: tuning fork perception neurologically and electrophysiologically (Notermans et al., 1994) . HMSN type 2 was diagnosed if patients had both (128 Hz) on middle finger for 15 s, or on the hallux (big toe) for 10 s ϭ 4, decreased on middle finger/hallux ϭ 3, an axonal polyneuropathy and a first degree relative with polyneuropathy, diagnosed by a neurologist. To exclude the ulnar styloid/medial malleolus ϭ 2, elbow/knee ϭ 1, clavicula/crista or higher ϭ 0. Joint position sense of middle demyelinative form of HMSN type 1, the median motor conduction velocity (MCV) had to be Ͼ38 m/s (Harding finger/hallux normal ϭ 2, diminished ϭ 1, absent ϭ 0.
Summation of all sensory modalities could lead to a maximum nerve, definite conduction block was defined as a reduction in the area of the CMAP of Ͼ50%, possible conduction total sensory score of 28 in the arms and 28 in the legs, i.e.
block as a reduction in CMAP amplitude of Ͼ30%, abnormal 56 in total. In addition, we performed the Romberg test and temporal dispersion as an increase of duration of Ͼ30%. The noted if muscle atrophy of arms and legs, and skeletal following concentric needle variables were scored: presence deformities such as pes cavus, claw toes and shortening of or absence of spontaneous muscle fibre activity (fibrillations, the calf muscles were present.
positive sharp waves or complex repetitive discharges), Disability was scored using the modified Rankin scale presence or absence of signs of reinnervation (polyphasic or (van Swieten et al., 1988) . Ability to walk and the use of giant motor unit potentials on light voluntary effort), pattern walking aids was noted.
(no activity, single, mixed or interference) on maximal Vibration perception treshold (VPT) was measured using voluntary effort. a Vibrameter type 3 (Somedic AB, Stockholm, Sweden) (Goldberg and Lindblom, 1979) . The measurements were performed on the dominant metacarpal 2 and corrected for Statistical analysis age (Halonen, 1986 
Results
was performed on 20 patients of both groups. Before the Onset of symptoms was significantly later and, in spite of investigation, the limbs were warmed in a bath of water of the age differences (mean 14 years), the duration of disease 37°C for 30 min (Franssen and Wieneke, 1994) and during was shorter in CIAP patients compared with HMSN type 2 the investigation skin temperature was maintained at 37°C patients (Table 1 , Fig. 1 ). Symptoms at presentation were by an infrared heating device. Nerve-conduction studies were more often sensory in CIAP patients and more often motor performed using surface stimulation and recording electrodes in HMSN type 2 patients (Table 1) . In both groups the initial according to standard techniques (Kimura, 1989) . Motor symptoms became manifest in the legs. Progression to the conduction was investigated in the median nerve (recording hands occurred more frequently in HMSN type 2 patients from the abductor pollicis brevis muscle) and in the tibial and consisted of weakness of the intrinsic hand muscles or nerve (recording from the abductor hallucis brevis muscle); numbness of the fingers. Muscle atrophy, mainly of the the distance between the distal stimulation point and the first interosseus and tibialis anterior muscle, and skeletal active recording electrode was 7 cm and 10 cm, respectively. deformities were significantly more frequent in HMSN type Sensory conduction was investigated in the median nerve 2 (Table 1) . Severe scoliosis or other spine deformities were (recording with ring electrodes from the second digit) and absent. Summed motor scores and summed sensory scores in the sural nerve (recording from the sural nerve at the for the arms were significantly lower in HMSN type 2 than ankle). To elicit F waves, 20 stimuli were applied to the in CIAP (Table 1) . The VPT was abnormal in 25 (52%) median nerve at the wrist and to the tibial nerve at the ankle.
CIAP patients and 28 (62%) HMSN type 2 patients (not Concentric needle recording was performed in the anterior significant). Pseudoathethosis was absent. Fasciculations were tibial muscle. present in 31% of the CIAP patients and 49% of the HMSN The following variables were measured. (i) Motor conductype 2 patients and were mainly seen in small hand muscles tion: distal motor latency (DML), maximal MCV, amplitude, and quadriceps muscles. A tremor was seen in 15% of CIAP duration and area of the negative part of the compound patients and in 28% of HMSN type 2 patients (not significant). muscle action potential (CMAP) after distal stimulation, In a separate analysis no sex differences were found for reduction of CMAP amplitude and area, and increase of clinical symptoms and signs. All data are presented as CMAP duration after distal compared with proximal stimulapercentages, mean Ϯ SD or median (range) tion, minimal central latency (shortest latency of F wave minus latency of M response). (ii) Sensory conduction: maximal sensory conduction velocity (SCV), amplitude and Disability duration of the negative part of the sensory nerve action Disability, measured with the Rankin scale, was more severe in HMSN type 2 patients; in HMSN, nine patients scored 1, potential (SNAP) after distal stimulation. For the median Mean Ϯ SD except where indicated otherwise. † Median with 25-75% percentiles in. *P Ͻ 0.05, **P Ͻ 0.001, ***P Ͻ 0.0001, χ 2 test and Wilcoxon signed rank test (otherwise not significant).
patients (P Ͻ 0.05). The number of patients with a reduced walking distance was equal in the two groups.
Age, duration and clinical course in HMSN type 2 and CIAP
Within the group of patients with HMSN type 2, older age and longer duration of the symptomatic stage were related to more severe disability as scored with the Rankin scale (P Ͻ 0.001, χ 2 test for trend). In CIAP patients, there was no relationship between age or duration of disease and Rankin score. Patients with pes cavus were younger (47 Ϯ 10 years) than those without (60 Ϯ 15 years) (P Ͻ 0.001). They also had an earlier age at onset [with pes cavus: 33 Ϯ 13 years, without pes cavus: 47 Ϯ 17 years (P Ͻ 0.05)]. In occur more frequently. Patients with claw toes were older (57 Ϯ 11 years) than those without (52 Ϯ 14 years) (P Ͻ 0.05). A relationship between claw toes and age at onset, or 30 patients scored 2 and eight patients scored 3. In CIAP, 16 scored 1, 29 scored 2 and three scored 3. Walking aids disease duration could not be established. Duration of disease was negatively correlated with summed motor score were used by 25 HMSN type 2 patients and by 13 CIAP (Pearson's correlation coefficient ϭ -0.3, P Ͻ 0.05) and (127 Ϯ 87 U/l, n ϭ 36, P Ͻ 0.01), 95% confidence limits 15-180 U/l. summed sensory score (-0.3, P Ͻ 0.05), but not with age or age at onset. In CIAP, no correlation was found between duration, age or age of onset, and motor and summed sensory score (Fig. 2) .
Electrophysiology
In HMSN type 2, compared with CIAP, the tibial nerve DML was significantly longer, also the sural nerve SCV HMSN type 2 patients and age of onset was significantly more reduced, and abnormalities on electromyography (spontaneous muscle fibre activity, signs (Ͻ40 years or Ͼ40 years)
Within the group of HMSN type 2 patients no effect of of reinnervation, reduced pattern on maximal voluntary effort) occurred more frequently (Table 3) . Only the median nerve age (Ͻ40 years or Ͼ40 years) could be demonstrated, apart from a shorter duration of disease and a lower prevalence MCV was more reduced in CIAP patients than in HMSN type 2 patients. For the other variables no significant of pes cavus in the late onset group (Table 2) . A comparison of HMSN type 2 patients with age of onset Ͼ40 years and differences were found between the groups. Values outside the normal limit were equally distributed over CIAP and CIAP patients showed no other differences from those that were found in the comparison of the complete groups.
HMSN type 2 patients (χ 2 test). Correction for height or sex did not alter the findings. In one patient only (from the CIAP group), there was evidence of possible conduction block (reduction in amplitude of 65% and area of 40%) and
Laboratory tests
Serum CK levels were significantly higher in HMSN type 2 increased temporal dispersion (increase in duration of 133%) found in the lower arm segment of the median nerve. patients (207 Ϯ 179 U/l, n ϭ 43) than in CIAP patients, patients. The higher incidence of skeletal deformities also indicates an earlier age of onset. Electrophysiological studies showed more denervation of the tibialis anterior considered after the first neurological evaluation. This was indeed considered in all patients, except in one in whom muscle, a longer DML of the tibial nerve and a slower conduction velocity of the sural nerve in HMSN type 2 the diagnosis 'idiopathic polyneuropathy' was made since the family history only later became positive when a younger patients. This indicates a more severe polyneuropathy with more pronounced motor abnormalities in HMSN type 2 sister of the patient developed the same symptoms. Because CIAP patients are likely to have a heterogeneous aetiology, patients compared with CIAP patients. The slower MCV of the median nerve in CIAP patients could be explained by it is of course possible that there are HMSN type 2 patients among this group with no family history. This problem will the older age of these patients. Dyck et al. (1981) found in their study on inherited and acquired polyneuropathies the not be solved until a genetic diagnosis of HMSN type 2 is possible. same predominance of motor symptoms at onset and skeletal deformities in the group with inherited polyneuropathies.
Duration of disease was longer in HMSN type 2 patients than in CIAP patients. This may explain the differences Their study consisted of a heterogeneous group of inherited polyneuropathies and was not focussed on HMSN type 2.
found at the time of our study since for both CIAP and HMSN type 2, deterioration over time has been described Hereditary polyneuropathies were often not recognized at the first evaluation because kinship history was unclear. We (Harding and Thomas, 1980a; Bercianio et al., 1986; MacMillan and Harper, 1994; Notermans et al., 1994) . In a therefore evaluated, in our index HMSN type 2 patients, whether the diagnosis 'hereditary polyneuropathy' had been comparison of CIAP patients with a subgroup of HMSN type
